Chinese medical drugs for coronavirus disease 2019: a systematic review and meta-analysis
Background: Integration of Chinese medical drugs (CMD) and western medicine (WM) has been widely used in the treatment of Coronavirus Disease 2019 (COVID-19). This systematic review aimed to evaluate the efficacy and safety of CMD for COVID-19. Method: A literature search was performed in six databa...
Main Authors: | Wentai Pang, Zhi Liu, Nan Li, Yuyun Li, Fengwen Yang, Bo Pang, Xinyao Jin, Wenke Zheng, Junhua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Integrative Medicine Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213422020301098 |
Similar Items
-
Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study
by: Wentai Pang, et al.
Published: (2020-09-01) -
Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
by: Xinyao Jin, et al.
Published: (2020-10-01) -
Evidence for the medicinal value of Squama Manitis (pangolin scale): A systematic review
by: Xinyao Jin, et al.
Published: (2021-03-01) -
PROSPERO's systematic review protocols of traditional Chinese medicine for COVID-19: An overview
by: Haiyin Hu, et al.
Published: (2021-01-01) -
A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
by: Geng Li, et al.
Published: (2019-01-01)